RxSight, Inc. to Present at the Bank of America Healthcare Conference
Rhea-AI Summary
RxSight, a specialized ophthalmic medical device company focused on post-cataract surgery vision customization, has announced its participation in the upcoming Bank of America Healthcare Conference in Las Vegas.
The company's management team is set to deliver their presentation on Wednesday, May 14, 2025, at 3:40 PM Pacific Time (6:40 PM Eastern Time). Investors and interested parties can access both the live presentation and archived recording through the company's investor relations website at https://investors.rxsight.com/.
This presentation at a major healthcare conference represents an opportunity for RxSight to showcase their innovations in customized vision solutions for cataract surgery patients. The company's participation in this significant industry event demonstrates their commitment to engaging with the investment community and sharing their business developments.
Positive
- Management participation in a major healthcare conference increases visibility with institutional investors
Negative
- None.
News Market Reaction
On the day this news was published, RXST gained 1.77%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference in Las Vegas.
RxSight’s management is scheduled to present on Wednesday, May 14, 2025, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the Bank of America Healthcare Conference 2025?
How can investors watch RxSight's presentation at the BofA Healthcare Conference?
What type of medical devices does RxSight (RXST) specialize in?
Where is the 2025 Bank of America Healthcare Conference with RxSight being held?
What time is RxSight's presentation in Eastern Time at the BofA Healthcare Conference?
